Search Results
Search for other papers by Kook Hwan Kim in
Google Scholar
PubMed
Severance Biomedical Research Institute, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei‐ro, Seodaemun‐gu, Seoul 120-752, Korea
Search for other papers by Myung-Shik Lee in
Google Scholar
PubMed
, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma; GLP1, glucagon-like peptide 1. The role of stress-induced FGF21 in physiological conditions FGF21 and nutritional status FGF21 expression is regulated by nutritional status, and changes in the FGF21
Search for other papers by Wenjuan Liu in
Google Scholar
PubMed
Search for other papers by Harry Kevin Lau in
Google Scholar
PubMed
Search for other papers by Dong Ok Son in
Google Scholar
PubMed
Division of Advanced Diagnostics, Toronto General Research Institutes, University Health Network, Toronto, Ontario, Canada
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada
Search for other papers by Tianru Jin in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Search for other papers by Gerald J Prud’homme in
Google Scholar
PubMed
Search for other papers by Qinghua Wang in
Google Scholar
PubMed
the β-cell mass and provide improved treatments for T1D and T2D subjects. Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gastrointestinal L cells in response to food ingestion, and has been currently used for the treatment of T2
Search for other papers by Jung-Hoon Kang in
Google Scholar
PubMed
Search for other papers by Seo-Yoon Chang in
Google Scholar
PubMed
Search for other papers by Hyun-Jong Jang in
Google Scholar
PubMed
Search for other papers by Dong-Bin Kim in
Google Scholar
PubMed
Search for other papers by Gyeong Ryul Ryu in
Google Scholar
PubMed
Search for other papers by Seung Hyun Ko in
Google Scholar
PubMed
Search for other papers by In-Kyung Jeong in
Google Scholar
PubMed
Search for other papers by Yang-Hyeok Jo in
Google Scholar
PubMed
Search for other papers by Myung-Jun Kim in
Google Scholar
PubMed
or reduce iNOS expression may be necessary for the prevention or inhibition of β-cell damage. Glucagon-like peptide-1 (GLP-1) and its potent agonist exendin-4 (EX-4) have received great attention because of their insulinotropic and β
Search for other papers by Srilaxmi Kalavalapalli in
Google Scholar
PubMed
Search for other papers by Fernando Bril in
Google Scholar
PubMed
Search for other papers by Joy Guingab in
Google Scholar
PubMed
Search for other papers by Ariana Vergara in
Google Scholar
PubMed
Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Search for other papers by Nishanth E Sunny in
Google Scholar
PubMed
Division of Endocrinology, Diabetes and Metabolism, Malcom Randall Veterans Administration Medical Center (VAMC), Gainesville, Florida, USA
Search for other papers by Kenneth Cusi in
Google Scholar
PubMed
under investigation for NASH, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown a significant promise for the treatment of NAFLD ( Ding et al. 2006 , Blonde & Russell-Jones 2009 , Cusi 2012 , Armstrong et al. 2013 , 2016 a , b
Department of Cardiovascular Disease Research, Novo Nordisk, Måløv, Denmark
Search for other papers by Katrine Dahl Bjørnholm in
Google Scholar
PubMed
Search for other papers by Gro Klitgaard Povlsen in
Google Scholar
PubMed
Search for other papers by Maria Elm Ougaard in
Google Scholar
PubMed
Search for other papers by Charles Pyke in
Google Scholar
PubMed
Search for other papers by Günaj Rakipovski in
Google Scholar
PubMed
Search for other papers by Pernille Tveden-Nyborg in
Google Scholar
PubMed
Search for other papers by Jens Lykkesfeldt in
Google Scholar
PubMed
Search for other papers by Gry Freja Skovsted in
Google Scholar
PubMed
Gaoatswe G Lynch L Corrigan MA Woods C O’Connell J O’Shea D 2014 Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus . Diabetologia 57 781 – 784
Search for other papers by Weiwei Xu in
Google Scholar
PubMed
Search for other papers by Jamie Morford in
Google Scholar
PubMed
Search for other papers by Franck Mauvais-Jarvis in
Google Scholar
PubMed
induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival . Diabetologia 54 2067 – 2076 . ( https://doi.org/10.1007/s00125-011-2181-x ) 10.1007/s00125-011-2181-x 21567300 Lubahn DB Joseph DR Sullivan PM Willard
Gulbali Institute, Charles Sturt University, Wagga Wagga, NSW, Australia
Search for other papers by Elizabeth M Simpson in
Google Scholar
PubMed
Search for other papers by Iain J Clarke in
Google Scholar
PubMed
Search for other papers by Christopher J Scott in
Google Scholar
PubMed
Gulbali Institute, Charles Sturt University, Wagga Wagga, NSW, Australia
Search for other papers by Cyril P Stephen in
Google Scholar
PubMed
Search for other papers by Alexandra Rao in
Google Scholar
PubMed
Gulbali Institute, Charles Sturt University, Wagga Wagga, NSW, Australia
Search for other papers by Allan J Gunn in
Google Scholar
PubMed
OVX ewes ( Iqbal et al. 2006 ). Another circulating appetite-regulating peptide is glucagon-like peptide 1 (GLP-1) encoded by the preproglucagon gene ( GCG ) ( Huda et al. 2006 , Sandoval & D'Alessio 2015 , Sekar 2017 ). GLP-1 is an anorexigen
Search for other papers by Eun-Young Lee in
Google Scholar
PubMed
Search for other papers by Xilin Zhang in
Google Scholar
PubMed
Search for other papers by Junki Miyamoto in
Google Scholar
PubMed
Search for other papers by Ikuo Kimura in
Google Scholar
PubMed
Search for other papers by Tomoaki Taknaka in
Google Scholar
PubMed
Search for other papers by Kenichi Furusawa in
Google Scholar
PubMed
Search for other papers by Takahito Jomori in
Google Scholar
PubMed
Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Minato-ku, Japan
Search for other papers by Kosuke Fujimoto in
Google Scholar
PubMed
Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Minato-ku, Japan
Search for other papers by Satoshi Uematsu in
Google Scholar
PubMed
Search for other papers by Takashi Miki in
Google Scholar
PubMed
Introduction Oral ingestion of carbohydrate triggers secretion of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), the major incretins that inhibit the rise in blood glucose levels by potentiating insulin
Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada
Search for other papers by Erica Yeo in
Google Scholar
PubMed
Department of Medicine, University of Toronto, Toronto, ON, Canada
Search for other papers by Patricia L Brubaker in
Google Scholar
PubMed
Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada
Department of Obstetrics, Gynecology and Pediatrics, McMaster University, Hamilton, ON, Canada
Search for other papers by Deborah M Sloboda in
Google Scholar
PubMed
secretion, appetite regulation and gut motility) ( Gibbs et al. 1997 , Suzuki et al. 2010 ). However, of all the potential endocrine factors that could contribute to maternal metabolic adaptations to pregnancy, glucagon-like peptide-1 (GLP-1) is
Department of Metabolic Medicine, Hammersmith Hospital, Imperial College, London W12 ONN, UK
Search for other papers by Catia Martins in
Google Scholar
PubMed
Department of Metabolic Medicine, Hammersmith Hospital, Imperial College, London W12 ONN, UK
Search for other papers by Linda M Morgan in
Google Scholar
PubMed
Department of Metabolic Medicine, Hammersmith Hospital, Imperial College, London W12 ONN, UK
Search for other papers by Stephen R Bloom in
Google Scholar
PubMed
Department of Metabolic Medicine, Hammersmith Hospital, Imperial College, London W12 ONN, UK
Search for other papers by M Denise Robertson in
Google Scholar
PubMed
), peptide YY (PYY), glucagon-like peptide-1 (GLP-1) and pancreatic polypeptide (PP) ( Blundell 1991 , King et al. 1997 b ). These metabolic and endocrine signals are then received and processed by specific areas in the hypothalamus and brainstem